EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 6 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $192,000 | – | 19,136 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 450,763 | $4,499,000 | 0.46% |
| 683 Capital Management, LLC | 600,000 | $5,988,000 | 0.32% |
| CVI Holdings, LLC | 355,000 | $3,511,000 | 0.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 304,025 | $3,007,000 | 0.23% |
| Cowen Investment Management LLC | 50,000 | $499,000 | 0.19% |
| EcoR1 Capital, LLC | 200,000 | $1,996,000 | 0.09% |
| Exos Asset Management LLC | 10,485 | $104,000 | 0.08% |
| Granite Point Capital Management, L.P. | 200,000 | $1,996,000 | 0.07% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 99,996 | $998,000 | 0.06% |
| Hudson Bay Capital Management LP | 396,480 | $3,921,000 | 0.05% |